Intravenous fluid management in patients with acute hypertensive hemorrhagic stroke: A randomized controlled study
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
All the patients admitted to our hospital with acute hypertensive hemorrhagic stroke (based on clinical and radiological features) within a period of 72hrs from the onset of symptoms and consenting to be part of the study will be included after screening for inclusion and exclusion criteria.
1.Not willing to participate in the study or no informed consent.
2.Those with GCS less than or equal to 8 at admission.
3.Prepared for or received surgical intervention within 14 days.
4.Patients with co-morbid conditions like cardiac failure, low ejection fraction ( <40%), renal failure with admission serum creatinine more than 2, fluid overload, acute liver failure, liver cirrhosis, cancer under treatment, fever, or any conditions which require more aggressive hydration or blood or blood component transfusion at the time of admission.
5.Patients with sepsis, hypotension, DKA, electrolyte disturbances requiring urgent correction, requiring ICU admission or those with critical illness.
6.Life expectancy or any reasons for follow-up < 3 months.
7.Those who received fluid from other hospital before reaching our hospital.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients with good outcome defined by mRS score of 0-3Timepoint: 3 months
- Secondary Outcome Measures
Name Time Method Cardiac failure or evidence of fluid overloadTimepoint: Within 4days;Dehydration during hospital stayTimepoint: Till discharge;Duration of hospital stayTimepoint: At discharge;Worsening of NIHSS score by more than or equal to 3 points unexplained by another causeTimepoint: Within 4days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.